From symptom management to self-care and more, get strategies for managing your mental health when you have idiopathic ...

From identifying triggers to controlling your breathing and more: Learn how to control an IPF cough.

IPF patients showed reduced anxiety and depression scores one month post-COVID-19 vaccination, indicating improved mental health. The study emphasized the heightened COVID-19 risk for IPF patients, ...

IPF is a chronic lung disease with fibrous tissue formation, leading to respiratory decline and poor prognosis, affecting mainly older adults. Diagnosis is challenging due to its exclusionary nature, ...

CPFE is associated with worse lung function trajectories and transplant-free survival among patients with IPF and non-IPF fibrotic ILD.

Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.

PureTech Health (PRTC) announced results from ELEVATE IPF, a Phase 2b randomized, double-blind, active- and placebo-controlled, dose-ranging trial evaluating deupirfenidone at two dose levels three ...

Boehringer Ingelheim’s Jascayd receives European marketing approval to treat adults with IPF & progressive pulmonary fibrosis: Ingelheim, Germany Saturday, July 18, 2026, 15:00 ...

Generally well-tolerated with no serious adverse events, bronchospasm or diarrhea; no study drug discontinuations 90% of patients had no [60%] or mild [30%] cough~450 total inhalations administered in ...